Publication Name	World Journal of Hepatology
Manuscript ID	15864
Country	Greece

Received	2014-12-13 19:04
Peer-Review Started	2014-12-13 20:59
To Make the First Decision	2015-01-08 14:07
Return for Revision	2015-01-19 13:47
Revised	2015-02-09 21:38
Second Decision	2015-05-25 11:57
Accepted by Journal Editor-in-Chief	2015-05-26 15:29
Accepted by Executive Editor-in-Chief	2015-06-02 17:12
Articles in Press	2015-06-02 17:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-06-05 12:02
Publish the Manuscript Online	2015-06-29 17:40

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?
Manuscript Source	Invited Manuscript
All Author List	Chrysoula Pipili and Evangelos Cholongitas
Funding Agency and Grant Number
Corresponding Author	Evangelos Cholongitas, Assistant Professor of Internal Medicine, 4th Department of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, 49, Konstantinopoleos Street, 54642 Thessaloniki, Greece. cholongitas@yahoo.gr
Key Words	Liver transplantation; Decompensated cirrhosis; Hepatitis C; New antiviral agents; Sofosbuvir; Simeprevir; Daclatasvir; Recurrent hepatitis C
Core Tip	Treatment landscape for liver transplant (LT) candidates and recipients with chronic hepatitis C is rapidly shifting due to novel updated data on direct antiviral agents (DAAs); Patients with decompensated cirrhosis awaiting LT should be treated with the inter-feron (IFN)-free, new generation DAAs, with or without ribavirin (RBV) regimens; IFN-free combinations of sofosbuvir with other novel DAAs with or without RBV led to remarkable on-treatment virological response along with minimal adverse effects “on difficult to treat” LT recipients with recurrent hepatitis C - those with chronic hepatitis C genotype 1, decompensated cirrhosis with Child-Pugh stage B and C as well as previously intolerant or non responsive to IFN therapy; Evidence regarding the efficacy and safety of novel combinative treatments although are very promising, refer still to patients case series.
Publish Date	2015-06-29 17:40
Citation	Pipili C, Cholongitas E. Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand? World J Hepatol 2015; 7(12): 1606-1616
URL	http://www.wjgnet.com/1948-5182/full/v7/i12/1606.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i12.1606

Full Article (PDF)	WJH-7-1606.pdf
Full Article (Word)	WJH-7-1606.doc
Manuscript File	15864-Review.doc
Answering Reviewers	15864-Answering reviewers.pdf
Audio Core Tip	15864-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	15864-Conflict-of-interest statement.pdf
Copyright License Agreement	15864-Copyright assignment.pdf
Peer-review Report	15864-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	15864-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	15864-Scientific misconduct check.pdf
Scientific Editor Work List	15864-Scientific editor work list.pdf